NewsBenzingaProQR Therapeutics: BPA del tercer trimestre de $(0.10) supera la estimación de $(0.11); ventas de $5.933M superan la estimación de $5.350M ProQR Therapeutics: BPA del tercer trimestre de $(0.10) supera la estimación de $(0.11); ventas de $5.933M superan la estimación de $5.350M Benzinga 2026.11.12 12:07 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3